Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX).
- Disclosed ownership: 5.2%.
- Date of event: 09 Jun 2025.
BIOTECHNOLOGY VALUE FUND L P - 09 Jun 2025 SCHEDULE 13G Report for Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX)
- Filing Manager
- BIOTECHNOLOGY VALUE FUND L P
- Reporting Manager
- BVF PARTNERS L P/IL
- Symbol
- PTGX
- Shares outstanding
- 61,750,788 shares
- Disclosed Ownership
- 3,211,041 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 16 Jun 2025, 17:30:24 UTC
- Date of event
- 09 Jun 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 5.2% ownership in Protagonist Therapeutics, Inc Common Stock, $0.00001 par value per share (PTGX) on 09 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Jun 2025, 17:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (10)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.7% | 1,681,652 | 0 | 1,681,652 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.7% | 1,681,652 | 0 | 1,681,652 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.1% | 1,280,665 | 0 | 1,280,665 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.1% | 1,280,665 | 0 | 1,280,665 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 181,190 | 0 | 181,190 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 181,190 | 0 | 181,190 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4.8% | 2,962,317 | 0 | 2,962,317 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 5.2% | 3,211,041 | 0 | 3,211,041 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 5.2% | 3,211,041 | 0 | 3,211,041 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 5.2% | 3,211,041 | 0 | 3,211,041 | /s/ Mark N. Lampert | Mark N. Lampert |